190 related articles for article (PubMed ID: 26162288)
1. Prognostic value of plasma neutrophil gelatinase-associated lipocalin in patients with heart failure.
Villacorta H; Santos RA; Marroig MA; Pereira GP; Xavier AR; Kanaan S
Rev Port Cardiol; 2015; 34(7-8):473-8. PubMed ID: 26162288
[TBL] [Abstract][Full Text] [Related]
2. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
4. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin.
Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R
Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.
Maisel AS; Mueller C; Fitzgerald R; Brikhan R; Hiestand BC; Iqbal N; Clopton P; van Veldhuisen DJ
Eur J Heart Fail; 2011 Aug; 13(8):846-51. PubMed ID: 21791540
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.
Maisel AS; Wettersten N; van Veldhuisen DJ; Mueller C; Filippatos G; Nowak R; Hogan C; Kontos MC; Cannon CM; Müller GA; Birkhahn R; Clopton P; Taub P; Vilke GM; McDonald K; Mahon N; Nuñez J; Briguori C; Passino C; Murray PT
J Am Coll Cardiol; 2016 Sep; 68(13):1420-1431. PubMed ID: 27659464
[TBL] [Abstract][Full Text] [Related]
8. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
[TBL] [Abstract][Full Text] [Related]
9. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
Elsharawy S; Raslan L; Morsy S; Hassan B; Khalifa N
Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566
[TBL] [Abstract][Full Text] [Related]
10. Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure.
Damman K; Valente MAE; van Veldhuisen DJ; Cleland JGF; O'Connor CM; Metra M; Ponikowski P; Cotter G; Davison B; Givertz MM; Bloomfield DM; Hillege HL; Voors AA
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698481
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.
Alvelos M; Lourenço P; Dias C; Amorim M; Rema J; Leite AB; Guimarães JT; Almeida P; Bettencourt P
Int J Cardiol; 2013 Apr; 165(1):51-5. PubMed ID: 21872946
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.
Pronschinske KB; Qiu S; Wu C; Kato TS; Khawaja T; Takayama H; Naka Y; Templeton DL; George I; Farr MA; Mancini DM; Schulze PC
J Heart Lung Transplant; 2014 Dec; 33(12):1215-22. PubMed ID: 25049066
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Neutrophil Gelatinase Associated Lipocalin, Neutrophil-to-Lymphocyte Ratio, Atrial Fibrillation and Renal Dysfunction in Chronic Heart Failure.
Argan O; Ural D; Kozdag G; Sahin T; Bozyel S; Aktas M; Karauzum K; Yilmaz I; Dervis E; Agir A
Med Sci Monit; 2016 Dec; 22():4765-4772. PubMed ID: 27918494
[TBL] [Abstract][Full Text] [Related]
14. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
[TBL] [Abstract][Full Text] [Related]
15. The association among biomarkers of renal and heart function in patients with heart failure: the role of NGAL.
Oikonomou E; Tsalamandris S; Karlis D; Siasos G; Chrysohoou C; Vogiatzi G; Dimitropoulos S; Charalambous G; Kouskouni E; Tousoulis D
Biomark Med; 2018 Dec; 12(12):1323-1330. PubMed ID: 30511581
[TBL] [Abstract][Full Text] [Related]
16. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL;
Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804
[TBL] [Abstract][Full Text] [Related]
17. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
Poniatowski B; Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Dobrzycki S
Kidney Blood Press Res; 2009; 32(2):77-80. PubMed ID: 19287180
[TBL] [Abstract][Full Text] [Related]
18. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
Nymo SH; Ueland T; Askevold ET; Flo TH; Kjekshus J; Hulthe J; Wikstrand J; McMurray J; Van Veldhuisen DJ; Gullestad L; Aukrust P; Yndestad A
J Intern Med; 2012 May; 271(5):436-43. PubMed ID: 22211640
[TBL] [Abstract][Full Text] [Related]
19. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease.
Hasegawa M; Ishii J; Kitagawa F; Takahashi H; Sugiyama K; Tada M; Kanayama K; Takahashi K; Hayashi H; Koide S; Nakai S; Ozaki Y; Yuzawa Y
Biomed Res Int; 2016; 2016():8761475. PubMed ID: 27051671
[TBL] [Abstract][Full Text] [Related]
20. Worsening Renal Function and Congestion in Patients with Acute Heart Failure: A Study with Bioelectrical Impedance Vector Analysis (BIVA) and Neutrophil Gelatinase-Associated Lipocalin (NGAL).
Villacorta H; Villacorta AS; Villacorta LSC; Xavier AR; Kanaan S; Rohen FM; Albuquerque LD; Bastilho DD; Cudischevitch CO
Arq Bras Cardiol; 2021 Apr; 116(4):715-724. PubMed ID: 33886716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
